Cubist Systematic Strategies LLC Acquires New Shares in Ardent Health, Inc. $ARDT

Key Points

• Cubist Systematic Strategies LLC has made a significant investment in Ardent Health, purchasing approximately 209,902 shares worth $2.89 million.
• Ardent Health recently reported a better-than-expected quarterly EPS of $0.52, surpassing analysts' estimates, alongside a revenue of $1.65 billion.
• Research analysts generally view Ardent Health positively, with a consensus rating of "Moderate Buy" and an average price target of $19.56.

Cubist Systematic Strategies LLC bought a new stake in Ardent Health, Inc. (NYSE:ARDT - Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 209,902 shares of the company's stock, valued at approximately $2,886,000. Cubist Systematic Strategies LLC owned approximately 0.15% of Ardent Health as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also made changes to their positions in the business. Graham Capital Management L.P. acquired a new position in Ardent Health during the 1st quarter worth about $598,000. Quarry LP raised its stake in shares of Ardent Health by 1,519.4% in the first quarter. Quarry LP now owns 5,020 shares of the company's stock worth $69,000 after acquiring an additional 4,710 shares during the last quarter. State of Wyoming lifted its position in shares of Ardent Health by 25.7% during the first quarter. State of Wyoming now owns 39,851 shares of the company's stock worth $548,000 after purchasing an additional 8,158 shares in the last quarter. Trexquant Investment LP bought a new stake in shares of Ardent Health during the first quarter valued at approximately $1,537,000. Finally, Corebridge Financial Inc. increased its holdings in shares of Ardent Health by 91.6% in the first quarter. Corebridge Financial Inc. now owns 11,687 shares of the company's stock valued at $161,000 after purchasing an additional 5,586 shares in the last quarter.

Ardent Health Trading Up 1.6%

NYSE ARDT traded up $0.21 on Thursday, reaching $13.24. The company had a trading volume of 336,891 shares, compared to its average volume of 271,535. Ardent Health, Inc. has a 52 week low of $10.10 and a 52 week high of $20.72. The stock's 50 day moving average is $12.32 and its 200-day moving average is $13.15. The company has a quick ratio of 2.00, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. The stock has a market cap of $1.89 billion, a price-to-earnings ratio of 7.31, a PEG ratio of 5.76 and a beta of 0.30.

Ardent Health (NYSE:ARDT - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.30 by $0.22. The firm had revenue of $1.65 billion for the quarter, compared to analysts' expectations of $1.54 billion. Ardent Health had a return on equity of 16.66% and a net margin of 4.11%. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. Equities analysts predict that Ardent Health, Inc. will post 1.23 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. Stephens reaffirmed an "overweight" rating and set a $21.00 price objective on shares of Ardent Health in a report on Tuesday, May 20th. JPMorgan Chase & Co. decreased their price target on Ardent Health from $18.00 to $15.00 and set a "neutral" rating on the stock in a report on Monday, August 11th. Bank of America lowered Ardent Health from a "neutral" rating to an "underperform" rating and lowered their price objective for the stock from $15.50 to $14.60 in a research report on Wednesday, July 16th. KeyCorp cut their target price on shares of Ardent Health from $24.00 to $20.00 and set an "overweight" rating on the stock in a research report on Thursday, August 7th. Finally, Wall Street Zen upgraded shares of Ardent Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. Nine analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $19.33.

About Ardent Health

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.